Management of Locally Advanced Cancer Cervix an Indian Perspective

被引:4
作者
Singh, J. K. [1 ]
Chauhan, Richa [2 ]
机构
[1] SS Hosp & Res Ctr, Patna, Bihar, India
[2] Mahavir Canc Sansthan, Dept Radiotherapy, Patna, Bihar, India
关键词
Cervical cancer; chemotherapy; toxicity; radiation;
D O I
10.2174/1574887110666150923113427
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cervical cancer has a major impact on the lives of Indian women with an estimated 122, 844 new cases of cervical cancer in the year 2012. About 80% of these cases present in a locally advanced stage leading to high morbidity and mortality. Because of lack of public awareness and infrastructure for screening and early detection in developing countries, this late presentation is likely to continue in the coming years. Radiation therapy has been the treatment of choice for patients with locally advanced cancer cervix. Many clinical trials and meta-analyses have shown a significant improvement in overall and progression-free survival with decreased local and distant recurrences with the use of concurrent chemotherapy with radiation. Most of these trials have been done in women from developed countries where the patient and disease profile are entirely different from ours. Recently, few trials from India have also shown promising results in locally advanced cancer cervix with concurrent chemoradiotherapy but toxicities remain a major concern. Further exploration is required for the use of concurrent chemo radiation prior to incorporating it into routine clinical practice.
引用
收藏
页码:298 / 301
页数:4
相关论文
共 51 条
[1]   Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French cooperative study: Update and multivariate analysis of prognostics factors [J].
Barillot, I ;
Horiot, JC ;
Pigneux, J ;
Schraub, S ;
Pourquier, H ;
Daly, N ;
Bolla, M ;
Rozan, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05) :969-978
[2]   SURVIVAL AND PATTERNS OF RECURRENCE IN CERVICAL-CANCER METASTATIC TO PERIAORTIC LYMPH-NODES - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
BERMAN, ML ;
KEYS, H ;
CREASMAN, W ;
DISAIA, P ;
BUNDY, B ;
BLESSING, J .
GYNECOLOGIC ONCOLOGY, 1984, 19 (01) :8-16
[3]   PHARMACOLOGIC REQUIREMENTS FOR OBTAINING SENSITIZATION OF HUMAN-TUMOR CELLS-INVITRO TO COMBINED 5-FLUOROURACIL OR FTORAFUR AND X-RAYS [J].
BYFIELD, JE ;
CALABROJONES, P ;
KLISAK, I ;
KULHANIAN, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11) :1923-1933
[4]  
CHAUVERGNE J, 1988, P AN M AM SOC CLIN, V7, P524
[5]  
COIA L, 1990, CANCER-AM CANCER SOC, V66, P2451, DOI 10.1002/1097-0142(19901215)66:12<2451::AID-CNCR2820661202>3.0.CO
[6]  
2-5
[7]   Does the evidence support the use of concurrent chemoradiotherapy as a standard in the management of locally advanced cancer of the cervix, especially in developing countries? [J].
Datta, NR ;
Agrawal, S .
CLINICAL ONCOLOGY, 2006, 18 (04) :306-312
[8]   Cervical cancer treatment in Africa [J].
Denny, Lynette .
CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) :469-474
[9]  
Ferlay Jacques, 2013, J CLIN ONCOL, V31, P4550
[10]  
FLETCHER GH, 1973, BRIT J RADIOL, V46, P1